STADA ARZNEIMI Current Ratio 2017-2018 | STDAF

Current and historical current ratio for STADA ARZNEIMI (STDAF) from 2017 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. STADA ARZNEIMI current ratio for the three months ending June 30, 2018 was .
STADA ARZNEIMI Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-06-30 $0.00B 0.00
2018-03-31 $0.00B 0.00
2017-12-31 $0.00B 0.00
2017-06-30 $0.00B 0.00
2017-03-31 $0.00B 0.00
2016-12-31 $0.00B 0.00
2016-09-30 $0.00B 0.00
2016-06-30 $0.00B 0.00
2016-03-31 $0.00B 0.00
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $5.375B $2.614B
Stada Arzneimittel AG manufactures pharmaceuticals for pain, women's health, cardiovascular conditions and diabetes. The company's branded product consists of Grippostad (R) and Ladival(R). Stada Arzneimittel AG is headquartered in Bad Vilbel, Germany.
Stock Name Country Market Cap PE Ratio
Takeda Pharmaceutical (TAK) Japan $62.374B 9.86
Zoetis (ZTS) United States $55.370B 33.12
Astellas Pharma (ALPMY) Japan $31.354B 15.66
Eisai (ESALY) Japan $18.833B 36.31
Merck (MKGAF) Germany $15.199B 20.74
Grifols, S.A (GRFS) Spain $14.885B 18.99
UCB SA (UCBJF) Belgium $14.669B 0.00
Neurocrine Biosciences (NBIX) United States $10.118B 477.70
Ono Pharmaceutical (OPHLF) Japan $9.450B 20.20
IPSEN SA ADR (IPSEY) France $8.953B 0.00
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $8.638B 0.00
Ionis Pharmaceuticals (IONS) United States $8.129B 16.46
Jazz Pharmaceuticals (JAZZ) Ireland $7.571B 9.67
Sage Therapeutics (SAGE) United States $7.295B 0.00
Catalent (CTLT) United States $7.185B 29.23
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.214B 0.00
Orion OYJ (ORINY) Finland $5.849B 30.12
Hypermarcas (HYPMY) Brazil $5.178B 18.61
Arrowhead Pharmaceuticals (ARWR) United States $4.598B 105.43
United Therapeutics (UTHR) United States $3.929B 0.00
Nektar Therapeutics (NKTR) United States $3.418B 0.00
FibroGen (FGEN) United States $3.052B 89.69
Evotec AG (EVTCY) Germany $3.051B 49.93
Taro Pharmaceutical Industries (TARO) Israel $2.937B 10.73
PTC Therapeutics (PTCT) United States $2.633B 0.00
Portola Pharmaceuticals (PTLA) United States $2.091B 0.00
Xencor (XNCR) United States $2.040B 62.00
Zogenix (ZGNX) United States $2.005B 0.00
Tilray (TLRY) Canada $1.986B 0.00
Corcept Therapeutics (CORT) United States $1.888B 22.94
Heron Therapeutics (HRTX) United States $1.877B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.819B 58.00
Pacira Pharmaceuticals (PCRX) United States $1.777B 52.57
USANA Health Sciences (USNA) United States $1.561B 16.66
CLINIGEN GP (CLIGF) United Kingdom $1.244B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.221B 20.14
Radius Health (RDUS) United States $1.095B 0.00
Theravance Biopharma (TBPH) Cayman Islands $1.005B 0.00
Karyopharm Therapeutics (KPTI) United States $0.964B 0.00
ArQule (ARQL) United States $0.945B 0.00
Endo (ENDP) Ireland $0.943B 1.73
Spectrum Pharmaceuticals (SPPI) United States $0.907B 0.00
Aerie Pharmaceuticals (AERI) United States $0.844B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $0.811B 5.53
TherapeuticsMD (TXMD) United States $0.746B 0.00
Organogenesis Holdings (ORGO) United States $0.740B 0.00
Collegium Pharmaceutical (COLL) United States $0.613B 0.00
Flexion Therapeutics (FLXN) United States $0.610B 0.00
Concordia (CXRXF) Canada $0.552B 0.00
Translate Bio (TBIO) United States $0.550B 0.00
ChemoCentryx (CCXI) United States $0.508B 0.00
ImmunoGen (IMGN) United States $0.490B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.485B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.484B 58.75
Aptorum Group (APM) Hong Kong, SAR China $0.455B 0.00
Crinetics Pharmaceuticals (CRNX) United States $0.445B 0.00
OptiNose (OPTN) United States $0.413B 0.00
Dermira (DERM) United States $0.411B 0.00
Siga Technologies (SIGA) United States $0.406B 9.28
BioSpecifics Technologies Corp (BSTC) United States $0.389B 16.76
Ardelyx (ARDX) United States $0.387B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.384B 0.00
Akebia Therapeutics (AKBA) United States $0.383B 0.00
Indivior (INVVY) United States $0.378B 1.37
Lannett Co Inc (LCI) United States $0.376B 4.37
Recro Pharma (REPH) United States $0.375B 0.00
Innate Pharma SA (IPHYF) France $0.372B 0.00
DURECT (DRRX) United States $0.367B 0.00
Harpoon Therapeutics (HARP) United States $0.325B 0.00
GlycoMimetics (GLYC) United States $0.282B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.278B 0.00
Molecular Templates (MTEM) United States $0.259B 0.00
Rafael Holdings (RFL) United States $0.256B 0.00
Xeris Pharmaceuticals (XERS) United States $0.215B 0.00
Foamix Pharmaceuticals (FOMX) Israel $0.211B 0.00
KalVista Pharmaceuticals (KALV) United States $0.195B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.186B 0.00
Nature's Sunshine Products (NATR) United States $0.185B 31.83
Calithera Biosciences (CALA) United States $0.181B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.175B 0.00
Jounce Therapeutics (JNCE) United States $0.175B 2.34
La Jolla Pharmaceutical (LJPC) United States $0.164B 0.00
Concert Pharmaceuticals (CNCE) United States $0.164B 0.00
Taiwan Liposome (TLC) Taiwan $0.162B 0.00
Aquestive Therapeutics (AQST) United States $0.154B 0.00
Matinas Biopharma Holdings (MTNB) United States $0.146B 0.00
CV Sciences (CVSI) United States $0.142B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.138B 0.00
Redhill Biopharma (RDHL) Israel $0.135B 0.00
MEI Pharma (MEIP) United States $0.133B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.129B 0.00
Ocular Therapeutix (OCUL) United States $0.128B 0.00
CannTrust Holdings (CTST) Canada $0.126B 0.00
IMV INC (IMV) Canada $0.122B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.118B 0.00
Cardiome Pharma (CORV) Canada $0.111B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.108B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.093B 0.00
MediWound (MDWD) Israel $0.083B 0.00
Majesco Entertainment (PTE) United States $0.079B 0.00
Neos Therapeutics (NEOS) United States $0.078B 0.00
Otonomy (OTIC) United States $0.077B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.076B 22.64
Aclaris Therapeutics (ACRS) United States $0.074B 0.00
SCYNEXIS (SCYX) United States $0.068B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.067B 0.00
Generex Biotechnology (GNBT) United States $0.065B 0.00
Natural Alternatives (NAII) United States $0.064B 15.96
Opiant Pharmaceuticals (OPNT) United States $0.063B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.062B 0.00
Champions Oncology (CSBR) United States $0.060B 0.00
Genocea Biosciences (GNCA) United States $0.059B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.057B 0.00
Medicure (MCUJF) Canada $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Pharmaxis (PXSLY) Australia $0.055B 0.00
Novan (NOVN) United States $0.055B 0.00
RENEURON GP (RNUGF) United Kingdom $0.054B 0.00
IntelGenx Technologies (IGXT) Canada $0.053B 0.00
AgeX Therapeutics (AGE) United States $0.053B 0.00
Nivalis Therapeutics (ALPN) United States $0.051B 0.00
Capnia (SLNO) United States $0.049B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.049B 0.00
Bellicum Pharmaceuticals (BLCM) United States $0.046B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.045B 0.00
ElectroCore (ECOR) United States $0.044B 0.00
CTI BioPharma (CTIC) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.040B 0.00
Mannatechorporated (MTEX) United States $0.036B 0.00
Jaguar Animal Health (JAGX) United States $0.034B 0.00
Opexa Therapeutics (ACER) United States $0.032B 0.00
India Globalization Capital (IGC) United States $0.031B 0.00
Bio-Path Holdings (BPTH) United States $0.031B 0.00
Iterum Therapeutics (ITRM) Ireland $0.030B 0.00
Biomerica (BMRA) United States $0.030B 0.00
Mast Therapeutics (SVRA) United States $0.029B 0.00
IsoRay (ISR) United States $0.026B 0.00
PharmAthene (ALT) United States $0.025B 0.00
China SXT Pharmaceuticals (SXTC) China $0.023B 0.00
ProPhase Labs (PRPH) United States $0.021B 0.00
Melinta Therapeutics (MLNT) United States $0.019B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.016B 0.00
Flex Pharma (SLRX) United States $0.015B 0.00
NovaBay Pharmaceuticals (NBY) United States $0.015B 0.00
Heat Biologics (HTBX) United States $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.014B 0.00
Shineco (TYHT) China $0.013B 16.42
Regulus Therapeutics (RGLS) United States $0.013B 0.00
Lipocine (LPCN) United States $0.010B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.008B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.007B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.007B 0.00
Achieve Life Sciences (ACHV) United States $0.007B 0.00
RXi Pharmaceuticals (PHIO) United States $0.006B 0.00
VAXART, INC (VXRT) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.004B 0.00
Can-Fite Biopharma (CANF) Israel $0.003B 0.00
Midatech Pharma (MTP) United Kingdom $0.002B 0.00
Onconova Therapeutics (ONTX) United States $0.002B 0.00
Hemispherx BioPharma (AIM) United States $0.001B 0.00
Cytori Therapeutics Inc (PSTV) United States $0.001B 0.00
Advanced Accelerator Applications S.A (AAAP) France $0.000B 0.00